Pluri Inc. Assets, Noncurrent
Pluri Inc. (PLUR) had Assets, Noncurrent of $16.15 million as of 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:AssetsNoncurrent · last filed 2026-09-10
- 2026-06-30: Assets, Noncurrent $16.15M.
- 2026-03-31: Assets, Noncurrent $15.59M.
- 2025-12-31: Assets, Noncurrent $16.79M.
- 2025-09-30: Assets, Noncurrent $16.75M.
| Period end | Assets, Noncurrent |
|---|---|
| 2026-06-30 | $16.15M 10-K · filed 2026-09-10 |
| 2026-03-31 | $15.59M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $16.79M 10-Q · filed 2026-02-12 |
| 2025-09-30 | $16.75M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $16.59M 10-K · filed 2026-09-10 |
| 2025-03-31 | $9.95M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $8.49M 10-Q · filed 2025-02-11 |
| 2024-09-30 | $8.41M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $8.42M 10-K · filed 2025-09-17 |
| 2024-03-31 | $9.02M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $9.31M 10-Q · filed 2024-02-12 |
| 2023-09-30 | $9.28M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $9.39M 10-K · filed 2024-09-18 |
| 2023-03-31 | $9.55M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $9.79M 10-Q · filed 2023-02-13 |
| 2022-09-30 | $10.03M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $10.32M 10-K · filed 2023-09-12 |
| 2022-03-31 | $14.81M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $21.03M 10-Q · filed 2022-02-07 |
| 2021-09-30 | $20.92M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $26.17M 10-K · filed 2022-09-21 |
| 2021-03-31 | $29.35M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $7.01M 10-Q · filed 2021-02-08 |
| 2020-09-30 | $16.26M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $17.07M 10-K · filed 2021-09-13 |
| 2020-03-31 | $5.20M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $5.63M 10-Q · filed 2020-02-06 |
| 2019-09-30 | $6.10M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $4.94M 10-K · filed 2020-09-10 |
| 2019-03-31 | $5.54M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $5.95M 10-Q · filed 2019-02-06 |
| 2018-09-30 | $6.44M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $6.92M 10-K · filed 2019-09-12 |
| 2018-03-31 | $7.26M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $7.66M 10-Q · filed 2018-02-06 |
| 2017-09-30 | $8.11M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $8.52M 10-K · filed 2018-09-12 |
| 2017-03-31 | $8.94M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $9.35M 10-Q · filed 2017-02-08 |
| 2016-09-30 | $9.89M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $10.35M 10-K · filed 2017-09-07 |
| 2016-03-31 | $10.86M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $11.26M 10-Q · filed 2016-02-08 |
| 2015-09-30 | $11.50M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $11.29M 10-K · filed 2016-09-07 |
| 2015-03-31 | $10.75M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $11.21M 10-Q · filed 2015-02-05 |
| 2014-09-30 | $11.54M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $12.04M 10-K · filed 2015-09-09 |
| 2014-03-31 | $12.68M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $12.93M 10-Q · filed 2014-02-05 |
| 2013-09-30 | $13.02M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $13.23M 10-K · filed 2014-09-11 |
| 2013-03-31 | $13.23M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $12.85K 10-Q · filed 2013-01-31 |
| 2012-09-30 | $11.46M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $9.23M 10-K · filed 2013-09-11 |
| 2012-03-31 | $5.44M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $5.80M 10-Q · filed 2012-02-09 |
| 2011-09-30 | $3.48M 10-Q · filed 2011-11-09 |
| 2011-06-30 | $2.72M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |